Home/Foundations/Pacific Heart Lung & Blood Institute

Pacific Heart Lung & Blood Institute

EIN: 38-3668906 • Los Angeles, CA • Form 990 Public Charity
Grantmaking Status: No Recent Grants Reported (Last Award Year: 2023)

In its most recent IRS Form 990 filing (Tax Year 2023), Pacific Heart Lung & Blood Institute reported $300K in total assets and $0 in grant distributions. Its last documented institutional grants occurred in 2022–2023 ($855K across historical awards). Confirm current program activity before submitting a funding inquiry.

Total Assets
$300K
Latest IRS filing (2023)
Latest Annual Giving
$0 (2023 Filing)
$855K historical (2022–2023)
Typical Grant
$455,000
Historical range: $400K – $455K
Application Status
Accepts New Applicants
Rolling review

Grantmaking Signals & Applicant Fit

Historical giving patterns derived from IRS filings (2022–2023)
New-Grantee Rate
37% First-Time Recipients
High new-grantee openness
3-Year Giving Trajectory
Giving Stable
Multi-year budget trajectory
Multi-Year Renewal Rate
0% Repeat Grantees
Project-grant focused
IRS 5% Payout Status
Exempt (Form 990 Public Charity)
Not subject to private foundation 5% rule
Applicant Takeaway:

Across its documented grant history, 37% of awards went to first-time recipients, while its latest 2023 Form 990 reported $0 in new grantmaking. Cold applicants should prioritize active grantmakers with higher new-grantee rates (35%+).

About Pacific Heart Lung & Blood Institute Grantmaking

Pacific Heart Lung & Blood Institute is an institutional nonprofit organization headquartered in Los Angeles, CA (EIN: 38-3668906). According to IRS Form 990 filings, the organization maintains $300K in total assets in its latest 2023 return, with $0 in grant distributions in its latest filing and $855K across historical awards. Its typical award size is $455,000, with the middle 50% of awards falling between $400K and $455K. Its primary funding focus includes Education & Literacy (100%), with the highest concentration of grants awarded in CA (53%) and OR (47%).

Top Funded Causes% Capital
Education & Literacy100%
$455K deployed1 award
Top Recipient States% Dollars
CA State Recipients53%
$455K funded1 grant
OR State Recipients47%
$400K funded1 grant
Grant Size DistributionAward Scale
Major Grants ($100K+)100%
2 large institutional grants
Mid-Sized ($25K–$100K)0%
0 standard program grants
Micro & Small (<$25K)0%
0 grassroots micro-awards
Application Guidelines & Deadlines
Application Policy
Accepts Unsolicited Proposals
Submission Deadlines

Rolling review

Geographic Focus & Restrictions

CA statewide and regional focus • Top giving states: CA (53%), OR (47%)

Program Officer & Direct Contacts

Unlock Direct Officer Contacts

Create an account to reveal direct program officer telephone numbers, extensions, and application review notes.

Create Free Account to Unlock →
Recent Grant AwardsShowing 2 of 2 recorded awards
Recipient OrganizationLocationTax YearAward AmountGrant Purpose
The Ucla FoundationPasadena, CA2023$455,000Support research on mesothelioma at ucla
Ohsu FoundationPortland, OR2023$400,000Donation to ohsu for research

Frequently Asked Questions about Pacific Heart Lung & Blood Institute

Does Pacific Heart Lung & Blood Institute accept unsolicited grant proposals?

Yes, Pacific Heart Lung & Blood Institute accepts unsolicited grant proposals. Submission review cycle: Rolling review.

What is the typical grant size from Pacific Heart Lung & Blood Institute?

The median grant size from Pacific Heart Lung & Blood Institute is $455,000, with the middle 50% of awards ranging between $400K and $455K.

What causes does Pacific Heart Lung & Blood Institute fund?

Over recent Form 990-PF filings, Pacific Heart Lung & Blood Institute's primary funding areas have been Education & Literacy.

How do I contact Pacific Heart Lung & Blood Institute about a grant?

Pacific Heart Lung & Blood Institute is headquartered in Los Angeles, CA. NPO Grant subscribers can access direct program officer telephone extensions, primary office numbers, and detailed submission guidelines.